These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39083101)

  • 1. The ADVanced Organ Support (ADVOS) hemodialysis system removes IL-6: an in vitro proof-of-concept study.
    Himmelein S; Perez Ruiz de Garibay A; Brandel V; Zierfuß F; Bingold TM
    Intensive Care Med Exp; 2024 Jul; 12(1):66. PubMed ID: 39083101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure.
    Fuhrmann V; Weber T; Roedl K; Motaabbed J; Tariparast A; Jarczak D; de Garibay APR; Kluwe J; Boenisch O; Herkner H; Kellum JA; Kluge S
    Ann Intensive Care; 2020 Jul; 10(1):96. PubMed ID: 32676849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory and metabolic acidosis correction with the ADVanced Organ Support system.
    Perez Ruiz de Garibay A; Kellum JA; Honigschnabel J; Kreymann B
    Intensive Care Med Exp; 2019 Sep; 7(1):56. PubMed ID: 31535309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the ADVanced Organ Support (ADVOS) system in critically ill patients with multiple organ failure.
    Acharya M; Berger R; Popov AF
    Artif Organs; 2022 May; 46(5):735-746. PubMed ID: 35128695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal carbon dioxide removal with the Advanced Organ Support system in critically ill COVID-19 patients.
    Allescher J; Rasch S; Wiessner JR; Perez Ruiz de Garibay A; Huberle C; Hesse F; Schulz D; Schmid RM; Huber W; Lahmer T
    Artif Organs; 2021 Dec; 45(12):1522-1532. PubMed ID: 34309036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF).
    Kaps L; Schleicher EM; Medina Montano C; Bros M; Gairing SJ; Ahlbrand CJ; Michel M; Klimpke P; Kremer WM; Holtz S; Boedecker-Lips SC; Galle PR; Kraus D; Schattenberg JM; Labenz C; Weinmann-Menke J
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal multiorgan support including CO
    Huber W; Lorenz G; Heilmaier M; Böttcher K; Sahm P; Middelhoff M; Ritzer B; Schulz D; Bekka E; Hesse F; Poszler A; Geisler F; Spinner C; Schmid RM; Lahmer T
    Int J Artif Organs; 2021 Apr; 44(4):288-294. PubMed ID: 32985328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia.
    Al-Chalabi A; Matevossian E; von Thaden A; Schreiber C; Radermacher P; Huber W; Perez Ruiz de Garibay A; Kreymann B
    Intensive Care Med Exp; 2017 Dec; 5(1):31. PubMed ID: 28677045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced Organ Support system in critically ill patients with liver failure-A retrospective analysis.
    Falkensteiner C; Kortgen A; Leonhardt J; Bauer M; Sponholz C
    Ther Apher Dial; 2021 Apr; 25(2):225-236. PubMed ID: 32515160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registry on extracorporeal multiple organ support with the advanced organ support (ADVOS) system: 2-year interim analysis.
    Fuhrmann V; Perez Ruiz de Garibay A; Faltlhauser A; Tyczynski B; Jarczak D; Lutz J; Weinmann-Menke J; Kribben A; Kluge S
    Medicine (Baltimore); 2021 Feb; 100(7):e24653. PubMed ID: 33607801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis.
    Huber W; Henschel B; Schmid R; Al-Chalabi A
    BMC Gastroenterol; 2017 Feb; 17(1):32. PubMed ID: 28209134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
    Kaps L; Ahlbrand CJ; Gadban R; Nagel M; Labenz C; Klimpke P; Holtz S; Boedecker S; Michel M; Kremer WM; Hilscher M; Galle PR; Kraus D; Schattenberg JM; Weinmann-Menke J
    PLoS One; 2021; 16(4):e0249342. PubMed ID: 33793644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study.
    Scharf C; Liebchen U; Paal M; Becker-Pennrich A; Irlbeck M; Zoller M; Schroeder I
    Sci Rep; 2021 May; 11(1):10190. PubMed ID: 33986443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Application for Albumin Dialysis in Extracorporeal Organ Support: Characterization of a Putative Interaction Between Human Albumin and Proinflammatory Cytokines IL-6 and TNFα.
    Pfensig C; Dominik A; Borufka L; Hinz M; Stange J; Eggert M
    Artif Organs; 2016 Apr; 40(4):397-402. PubMed ID: 26365493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of meropenem during advanced organ support (ADVOS
    König C; Kluge S; Fuhrmann V; Jarczak D
    Int J Artif Organs; 2021 Oct; 44(10):783-786. PubMed ID: 34144656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal albumin dialysis in critically ill patients with liver failure: Comparison of four different devices-A retrospective analysis.
    Sommerfeld O; Neumann C; Becker J; von Loeffelholz C; Roth J; Kortgen A; Bauer M; Sponholz C
    Int J Artif Organs; 2023 Sep; 46(8-9):481-491. PubMed ID: 37609875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system?
    Awad SS; Sawada S; Soldes OS; Rich PB; Klein R; Alarcon WH; Wang SC; Bartlett RH
    ASAIO J; 1999; 45(1):47-9. PubMed ID: 9952006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies.
    Mariano F; Fonsato V; Lanfranco G; Pohlmeier R; Ronco C; Triolo G; Camussi G; Tetta C; Passlick-Deetjen J
    Nephrol Dial Transplant; 2005 Jun; 20(6):1116-26. PubMed ID: 15814541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine dialysis: an ex vivo study.
    Uchino S; Bellomo R; Morimatsu H; Goldsmith D; Davenport P; Cole L; Baldwin I; Panagiotopoulos S; Tipping P; Morgera S; Neumayer HH; Goehl H
    ASAIO J; 2002; 48(6):650-3. PubMed ID: 12455777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.